Author:
Zhou Peng,Yang Xing-Lou,Wang Xian-Guang,Hu Ben,Zhang Lei,Zhang Wei,Si Hao-Rui,Zhu Yan,Li Bei,Huang Chao-Lin,Chen Hui-Dong,Chen Jing,Luo Yun,Guo Hua,Jiang Ren-Di,Liu Mei-Qin,Chen Ying,Shen Xu-Rui,Wang Xi,Zheng Xiao-Shuang,Zhao Kai,Chen Quan-Jiao,Deng Fei,Liu Lin-Lin,Yan Bing,Zhan Fa-Xian,Wang Yan-Yi,Xiao Geng-Fu,Shi Zheng-Li
Abstract
AbstractSince the outbreak of severe acute respiratory syndrome (SARS) 18 years ago, a large number of SARS-related coronaviruses (SARSr-CoVs) have been discovered in their natural reservoir host, bats1–4. Previous studies have shown that some bat SARSr-CoVs have the potential to infect humans5–7. Here we report the identification and characterization of a new coronavirus (2019-nCoV), which caused an epidemic of acute respiratory syndrome in humans in Wuhan, China. The epidemic, which started on 12 December 2019, had caused 2,794 laboratory-confirmed infections including 80 deaths by 26 January 2020. Full-length genome sequences were obtained from five patients at an early stage of the outbreak. The sequences are almost identical and share 79.6% sequence identity to SARS-CoV. Furthermore, we show that 2019-nCoV is 96% identical at the whole-genome level to a bat coronavirus. Pairwise protein sequence analysis of seven conserved non-structural proteins domains show that this virus belongs to the species of . In addition, 2019-nCoV virus isolated from the bronchoalveolar lavage fluid of a critically ill patient could be neutralized by sera from several patients. Notably, we confirmed that 2019-nCoV uses the same cell entry receptor—angiotensin converting enzyme II (ACE2)—as SARS-CoV.
Publisher
Springer Science and Business Media LLC
Cited by
16237 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献